These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9127459)
1. Effect of perindopril therapy on fluidity and potential of erythrocyte membrane from individuals with coronary heart disease. Piasecka A; Koter M; Buczyński A; Leyko W; Kedziora J; Tkaczewski W; Bryszewska M Scand J Clin Lab Invest; 1997 Feb; 57(1):65-71. PubMed ID: 9127459 [TBL] [Abstract][Full Text] [Related]
2. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426 [TBL] [Abstract][Full Text] [Related]
3. Effects of genistein and daidzein on erythrocyte membrane fluidity: an electron paramagnetic resonance study. Ajdzanović V; Spasojević I; Filipović B; Sosić-Jurjević B; Sekulić M; Milosević V Can J Physiol Pharmacol; 2010 Apr; 88(4):497-500. PubMed ID: 20555419 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effects of perindopril treatment in adult spontaneously hypertensive rats. Lee RM; Lu M; Gillies L; Werstiuk ES Can J Cardiol; 1997 Sep; 13(9):831-5. PubMed ID: 9343032 [TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia. Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855 [TBL] [Abstract][Full Text] [Related]
6. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study. Coccia R; Spadaccio C; Foppoli C; Perluigi M; Covino E; Lusini M; Chello M Clin Ther; 2007 Aug; 29(8):1706-17. PubMed ID: 17919551 [TBL] [Abstract][Full Text] [Related]
7. [The erythrocyte membrane structure in patients with mixed hyperlipidemia]. Broncel M; Balcerak M; Bała A; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J Wiad Lek; 2007; 60(1-2):4-9. PubMed ID: 17607961 [TBL] [Abstract][Full Text] [Related]
8. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril]. Rapezzi C; Ciliberti P; Graziosi M; Riva L Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516 [TBL] [Abstract][Full Text] [Related]
9. Immobilization-induced changes in erythrocyte membrane fluidity in rabbits: a spin-label electron spin resonance study. Liu M; Li J; Qin L; Lee KM; Chan KM Ann Clin Lab Sci; 2002; 32(4):399-403. PubMed ID: 12458893 [TBL] [Abstract][Full Text] [Related]
10. EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease. Simoons ML; Vos J; de Feyter PJ; Bots ML; Remme WJ; Grobbee DE; Kluft C; de Maat MP; Fox KM; Deckers JW Eur Heart J; 1998 Sep; 19 Suppl J():J56-60. PubMed ID: 9796842 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure. Sami M Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688 [TBL] [Abstract][Full Text] [Related]
12. [The protective effects of metallothionein on membrane proteins against endothelin--electron paramagnetic resonance spin labelling study]. Wang G; Hou L; Cheng S; Tang CS; An RS Sheng Li Xue Bao; 1994 Feb; 46(1):59-64. PubMed ID: 8085169 [TBL] [Abstract][Full Text] [Related]
13. Physicochemical modifications induced by statins therapy on human erythrocytes membranes. Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550 [TBL] [Abstract][Full Text] [Related]
14. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease. Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432 [TBL] [Abstract][Full Text] [Related]
15. Fluidity and fatty acid components of erythrocyte membranes in diabetic retinopathy. Yang G; Qiu H; Wang S; Deng H; Zhang S; Li L Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):407-12. PubMed ID: 10862451 [TBL] [Abstract][Full Text] [Related]
16. Electron spin resonance study of the erythrocyte membrane fluidity changes in diabetes. Preoteasa EA; Ionescu-Tîrgovişte C; Grecu VV; Georgescu R Rom J Intern Med; 1993; 31(4):271-82. PubMed ID: 8148779 [TBL] [Abstract][Full Text] [Related]
17. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure]. Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761 [TBL] [Abstract][Full Text] [Related]
18. Human red blood cell membrane potential and fluidity in glucose solutions. Zavodnik IB; Piasecka A; Szosland K; Bryszewska M Scand J Clin Lab Invest; 1997 Feb; 57(1):59-63. PubMed ID: 9127458 [TBL] [Abstract][Full Text] [Related]
19. [Change of circadian pattern of arterial pressure in patients with congestive heart failure treated with perindopril, an inhibitor of angiotensin-converting enzyme (ACE)]. Tereshchenko SN; Kobalova ZhD; Demidova IV; Moiseev VS Ter Arkh; 1997; 69(12):40-3. PubMed ID: 9503533 [TBL] [Abstract][Full Text] [Related]
20. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension. Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE; Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]